“US-based CEOCFO magazine interview with Devonian’s President & CEO”

“Biopharma acquisition provides commercialization edge”

An editorial piece from Stockhouse’s Jeff Nielson published in February 2018.

“Farm to Pharm: the Botanical Drug Revolution”

An editorial piece from Stockhouse’s Jeff Nielson published in September 2017.

“Devonian – In The Canadian Business Quarterly”

TSX-V listed company Devonian Health Group is a late-stage botanical pharmaceutical corporation.